GE HealthCare Gets FDA Approval for Portrait VSM in Expanding Patient Monitoring Lineup

GE HealthCare (Nasdaq: GEHC) has obtained FDA 510(k) clearance for its Portrait VSM vital signs monitor, enhancing clinical decision-making with precise patient vital sign data. Utilizing the SuperSTAT non-invasive blood pressure algorithm, Portrait VSM ensures accurate readings. Designed for user convenience, it offers wireless connectivity, seamless EMR integration, and customizable Early Warning Scores (EWS) to streamline workflows and automate routine tasks.

This innovation extends GE HealthCare’s Portrait monitoring solutions, integrating with Portrait Mobile for continuous patient monitoring and mobility. Through barcode scanning, Portrait VSM imports patient data and vital signs from Portrait Mobile, simplifying clinical rounding and charting.

Integrated workflow and EMR connectivity enhance vital sign charting accuracy, aiding timely treatment decisions and enabling early detection of patient decline. Traditional spot check methods, conducted every 4-6 hours, may miss early signs of deterioration, contributing to preventable consequences post-surgery.

Neal Sandy, GM of monitoring solutions at GE HealthCare, emphasizes Portrait VSM’s contribution to efficient patient monitoring, supporting care teams in spending more time with patients. It addresses challenges highlighted in GE HealthCare’s Reimagining Better Health study, offering workflow efficiencies and customizable EWS protocols to recognize early deterioration signs.

Built on a legacy of clinical advancements, GE HealthCare’s FlexAcuity monitoring solutions adapt to evolving patient needs. Recipient of design awards, including the iF Design Gold Award for Portrait Mobile in 2022 and an iF Design Award for CARESCAPE Canvas in 2023, GE HealthCare’s technology exemplifies innovation.

For further details on Portrait VSM and GE HealthCare’s Portrait monitoring solutions, visit: [link].

Source Link:

Newsletter Updates

Enter your email address below and subscribe to our newsletter